Nathan L. Scott, M.D.

August 23, 2024

Experts discuss unmet needs and challenges faced by patients with uveal melanoma. This program was made possible with support from Immunocore.

August 23, 2024

Nathan L. Scott, M.D., discusses the safety and efficacy of tebentafusp. This program was made possible with support from Immunocore.

August 23, 2024

Nathan L. Scott, M.D., provides a brief overview of the current guidelines for treatment of metastatic uveal melanoma, as well as what considerations go into choosing the appropriate treatment for it. This program was made possible with support from Immunocore.

August 23, 2024

Nathan L. Scott, M.D., discusses the risk of recurrence within diagnosed uveal melanoma patients. Uveal Melanoma Prognosis and Risk Stratification